Icecure Medical Ltd (ICCM) Return on Investment ROI from the fourth quarter of 2025 to fourth quarter of 2023 and for the year 2025, average high and low, overall ranking from Dec 31 2025 to Dec 31 2023 - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Icecure Medical Ltd  (NASDAQ: ICCM)


Icecure Medical Ltd's ROI from its fourth quarter of 2025 to the fourth quarter of 2023 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Icecure Medical Ltd's ROI in the fourth quarter of 2025?
Icecure Medical Ltd achieved a return on average invested assets (ROI) of 197.84 % in its fourth quarter of 2025 a new company high.

ROI fell compared to the third quarter of 2025, despite the net income growth of % from the third quarter of 2025.

Within the Healthcare sector 12 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the third quarter of 2025 from to 39.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Dec 31 2025)
IV. Quarter		 0
III. Quarter		 0
II. Quarter		 0
I. Quarter		 (Dec 31 2023)
IV. Quarter
Y / Y Investment Change TTM -28.61 % -47.74 % -45.68 % -42.7 % -48.17 %
Y / Y Net Income Change TTM 2.76 % - - - -
Investment (TTM) in Millions 9 9 3 9 7
Return On Investment (TTM) 197.84 % 206.07 % 193.71 % 148.21 % 137.44 %
ICCM's Overall Ranking # 39 # # # #
Seq. Investment Change TTM 7.04 % -6 % -23.49 % -7.27 % -21.64 %
Seq. Net Income Change TTM 2.76 % 0 % 0 % 0 % -
Net Income (TTM) in Millions 15 15 15 15 15

ICCM Company Profile >> Back to ICCM Roi Comparisons >> See Annual ICCM Return On Investment



Return On Investment ICCM's Ranking
Within: No.
Industry # 6
Sector # 13
Overall # 39

Return On Investment Statistics
High Average Low
197.84 %
159.15 %
120.46 %
(Dec 31 2025)   (Dec 31 2023)







Financial Statements
Icecure Medical Ltd's IV. Quarter Investments $ 9 Millions ICCM's Balance sheet
Icecure Medical Ltd's IV. Quarter Income $ 15 Millions Quarterly ICCM's Income Statement
ICCM's Income by Division See ICCM's Income by Division


ICCM Annual Return On Investment (Dec 31 2025)
2025		 (Dec 31 2024)
2024		 (Dec 31 2023)
2023		 (Dec 31 2022)
2022		 (Dec 31 2021)
2021
Total Investments in Millions 9 7 13 26 28
Y / Y Investment Growth 28.35 % -43.68 % -51.5 % -6.25 % -
Net Income in Millions 15 -15 15 -17 -10
Y / Y Net Income Growth - - - - -
Annual Return On Investment 166.12 % -216.91 % 116.85 % -65.67 % -35.88 %


Annual Roi Comment
In the fiscal year 2025 ROI improved to 166.12 % compared to the prior year, due to net income growth.

Definition and Formula of Return on Investment

Other ROI Ratios
Medical Equipment & Supplies Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
ICCM's Roi Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for ICCM's Competitors
Subscribers only: Roi for Icecure Medical Ltd's Suppliers
Subscribers only: Return On Investment for ICCM's Customers

Other Ratios
ICCM's Roa ICCM's Inventory Turnover Ratio ICCM's Growth Rates ICCM's Dividend Statistics
ICCM's Profitability Ratios ICCM's Asset Turnover Ratio ICCM's Dividend Growth
ICCM's Roe ICCM's Valuation Ratios ICCM's Financial Strength Ratios ICCM's Dividend Payout Ratio



Companies with similar Return On Investment at Dec 31 2025, within Healthcare Sector ROI
Glucotrack Inc   372.04 %
Elutia Inc   358.27 %
Oncotelic Therapeutics Inc   252.91 %
Atara Biotherapeutics Inc   242.55 %
Traws Pharma inc   234.73 %
Scisparc Ltd  234.01 %
Petros Pharmaceuticals inc   233.39 %
Omada Health Inc   200.69 %
Interpace Biosciences Inc   198.59 %
Rigel Pharmaceuticals Inc  185.38 %
Icecure Medical Ltd  166.12 %
Silexion Therapeutics Corp  142.64 %
Heartflow Inc   142.09 %
Capforce Inc   140.91 %
Check Cap Ltd  120.45 %
Coherus Oncology inc   119.44 %
Kyntra Bio Inc   118.89 %
Lifemd Inc   105.75 %
Biocryst Pharmaceuticals Inc   88.36 %
Advanced Biomed Inc.  84.64 %
Earth Science Tech Inc   78.43 %
Exelixis Inc   71.31 %
Entera Bio Ltd   63.91 %
Tg Therapeutics Inc   63.77 %
Aurinia Pharmaceuticals Inc   56.37 %
Pulmatrix Inc   53.09 %
Novavax inc   51.88 %
Q32 Bio Inc   50.33 %
Idexx Laboratories Inc  48.69 %
Theravance Biopharma inc   46.03 %

Date modified: 2026-07-07T11:26:19+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.